Call Today: 800-716-5901
Contact us for free information or to start a free case review.
A new lawsuit has been filed against Merck & Co. over its osteoporosis drug Fosamax. The suit claims the drug caused a Connecticut woman to suffer multiple stress fractures in her legs as well as suppressed bone regeneration.
Merck is already facing hundreds of Fosamax lawsuits claiming the drug caused a rare and disfiguring condition known as osteonecrosis of the jaw (ONJ), or decay of the jawbone.
Fosamax is one of Merck’s top-selling drugs, generating nearly $3 billion in sales last year alone.
In November, the company announced a $4.85 settlement to cover tens of thousands of Vioxx lawsuits. Merck pulled Vioxx from the market in 2004 when evidence showed the drug caused potentially deadly heart problems.
Injured by Fosamax? Contact an experienced attorney near you today to learn more about recovering compensation for your losses.
Copyright © 2001 - 2012 Online Lawyer Source
ATTORNEY ADVERTISEMENT—Thank you for your visit. The content published on this website was not written by medical professionals and should not, at any point, be mistaken for medical advice. Furthermore, the information on this site is intended for educational purposes only and should never interfere with a patient/site visitor and his or her healthcare provider. In addition, viewing the content on this website, requesting additional information, or transmitting information through a contact form should never be considered the formation of an attorney-client relationship. The material published on this site is general and may not apply to your specific circumstances. Every case comes with its own set of unique circumstances; past success discussed on this site does not guarantee future performance. Information found on this website should not be used as incentive to act without seeking counsel from a professional. For more information, please read our disclaimer.